- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT06441305
Ampliación de la cobertura del tratamiento de la desnutrición aguda grave (SAM) en Kenia (R-SWITCH)
Evaluación del impacto, la implementación y el costo de empoderar a los promotores de salud comunitarios para mejorar la cobertura del tratamiento de la emaciación en el condado de Turkana mediante la ampliación del MUAC dirigida por la familia, la evaluación del peso para la edad y el seguimiento de los morosos
Child wasting is a type of malnutrition which occurs when a child becomes too thin. This medical condition increases the risk of becoming sick or dying. A child with severe wasting needs to be seen in a medical consultation to check on health status and to receive some medicine and a medical food supplement for daily consumption until cured. Yet, only a small proportion of children suffering from severe wasting are presently receiving appropriate treatment.
In Kenya, there is an opportunity to build on the existing network of community health promoters (CHPs) to increase the number of children with wasting who are identified and treated. In intervention areas, CHPs will be equipped with smartphones and an application which provides guidance on household members to visit and simple actions to take, related to health. CHPs will distribute color-coded mid-upper arm circumference tapes to households with young children and train caregivers on how to use it. After training, CHPs will send Short Message Services (SMS) to remind caregivers to regularly measure the arm circumference of the child. In addition, CHPs will receive a scale to measure the weight of children every month. Finally, wasted children registered in the treatment program who fail to attend a planned consultation will be flagged to their CHP through the phone application, and CHPs will conduct a specific home visit to investigate and help solve potential issues.
The study will assess whether this community intervention (called SWITCH) allows to identify and treat more children suffering from severe wasting. Before the start of the intervention, the proportion of wasted children receiving treatment in 40 community units in Turkana South, Turkana East and Aroo will be assessed. After this survey, a computer will randomly select 20 community units where the intervention will be scaled up. The survey will be repeated after 2 years to assess if the proportion of severely wasted children receiving treatment is higher in the area where the intervention was scaled up compared to the area where it was not scaled up.
In addition, after 1 year of implementation, the study will assess how the intervention was scaled up, what are the main challenges, and what are the overall perceptions on the intervention in the community among those who receive it and those who deliver it. Finally, costs of the various components of the intervention will be measured for all actors involved, including for caregivers.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Despite the burden and impact of child wasting on morbidity and mortality, only a small proportion of severely wasted children are presently receiving treatment. In Kenya, there is an opportunity to strengthen the screening for wasting and the identification and treatment of wasted children (SWITCH) through community health promoters (CHPs) who, per policy, are trained, equipped, incentivized and supervised by community health agents (CHAs).
An intervention package will be implemented including: 1) Digitization to support CHPs, 2) Family-led Mid-Upper Arm Circumference (MUAC) enhanced by digitization, with a two-way messaging platform between CHP and caregivers, and reminders for timely training at 6 months of age, 3) Equipment of CHPs with a baby-mother scale for measurement of weight-for-age to detect likely wasting, and 4) Real-time follow-up in the community (facilitated by digitization) of defaulters and non-respondent children enrolled for wasting treatment.
A randomized controlled trial will be used to assess the impact of the SWITCH intervention on severe wasting treatment coverage in Turkana. Twenty randomly selected community units of 40 will receive the intervention. An exhaustive screening campaign conducted at baseline and endline (after 2 years) in the 40 community units will identify children with severe wasting (MUAC < 115 mm or Weight-for-Height Z-score < -3 or bilateral pitting oedema) or recovering from severe wasting (defined by receipt and consumption of Ready-to-Use Therapeutic Food), who will be enrolled in a survey assessing treatment coverage, program exposure and other pathways to impact, and confounders.
In addition, the study will assess the reach, adoption by CHPs, and implementation challenges of the SWITCH package through additional qualitative (interviews and observations) and quantitative data collection at all levels of program delivery (beneficiaries, CHPs, CHAs, program implementers); and the unit cost of the SWITCH package per beneficiary (and cost-effectiveness if the package is effective) through an activity-based costing-ingredients approach.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Lodwar, Kenia
- Turkana South and Turkana East and Aroo
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
-
Household in a village of the study area covered by a CHP (although the child may or may not be registered by a CHP) AND
-
Child is 6-59.9 months of age AND
-
Caregiver consents to be part of the study AND
-
any of the following:
- WHZ < -3 (relative to WHO 2006 reference) OR
- MUAC <115 mm OR
- Presence of bilateral edema OR
- receiving treatment as follow-up for an initial SAM condition on the way to full recovery
exclusion criteria is:
- Congenital malformation that makes anthropometric measurements impossible.
- Length is below 54 cm or height is above 120cm.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Standard of Care
|
|
|
Experimental: SWITCH intervention package
|
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Period prevalence of severe wasting (SAM) treatment coverage in children 6-59 months of age
Periodo de tiempo: After 24 months of program implementation
|
defined as the proportion of children suffering from SAM or recovering from SAM who currently receive treatment. • SAM defined by weight-for-height Z-score (WHZ) <-3 (relative to World Health Organization (WHO) 2006 reference) or MUAC <115 mm or by the presence of bilateral edema. Children recovering from SAM through treatment will be considered to receive treatment for an initial SAM condition if they both attended an IMAM consultation in the previous 15 days (as reported by caregiver OR by a consultation card) AND either:
|
After 24 months of program implementation
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Mean weight-for-height Z-score (WHZ)
Periodo de tiempo: After 24 months of program implementation
|
In 6-59 months old children.To calculate WHZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Mean mid-upper arm circumference (MUAC)
Periodo de tiempo: After 24 months of program implementation
|
In 6-59 months old children. |
After 24 months of program implementation
|
|
Point prevalence of SAM outpatient therapeutic program (OTP) treatment coverage in children 6-59 months of age
Periodo de tiempo: After 24 months of program implementation
|
Defined as the proportion of children with SAM at the time of the survey that are under treatment (see definition under primary outcome) |
After 24 months of program implementation
|
|
Screening coverage of SAM
Periodo de tiempo: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months suffering from SAM ((currently or on their way to recovery from SAM through treatment for an initial SAM condition) ) screened for wasting over the last 30 days (as reported by the caregiver) |
After 24 months of program implementation
|
|
Prevalence of SAM
Periodo de tiempo: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM (defined as WHZ <-3 (relative to World Health Organization (WHO) 2006 reference) or a MUAC < 115 mm or the presence of bilateral pitting edema). Also calculated on the restricted population of children aged 6-59 months suffering or recovering from SAM (same definition as for primary outcome) |
After 24 months of program implementation
|
|
Prevalence of very low WHZ
Periodo de tiempo: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with WHZ <-3 (relative to World Health Organization (WHO) 2006 reference). |
After 24 months of program implementation
|
|
Prevalence of very low MUAC
Periodo de tiempo: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with MUAC<115 mm |
After 24 months of program implementation
|
|
Prevalence of moderate acute malnutrition (MAM)
Periodo de tiempo: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with MAM (defined as -3<= WHZ <-2 (relative to World Health Organization (WHO) 2006 reference) or 115<= MUAC < 125 mm). Also calculated on the restricted population of children aged 6-59 months suffering or recovering from SAM (same definition as for primary outcome) |
After 24 months of program implementation
|
|
Prevalence of wasting
Periodo de tiempo: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with wasting (defined as WHZ <-2 (relative to World Health Organization (WHO) 2006 reference) or a MUAC < 125 mm or the presence of bilateral pitting edema). Also calculated on the restricted population of children aged 6-59 months suffering or recovering from SAM (same definition as for primary outcome) |
After 24 months of program implementation
|
|
Prevalence of stunting
Periodo de tiempo: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months suffering from SAM or recovering from SAM with stunting (defined as height-for-age Z-scores (HAZ) <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema). To calculate HAZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Prevalence of underweight and severe underweight
Periodo de tiempo: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months suffering from SAM or recovering from SAM with underweight (defined as weight-for-age Z-scores (WAZ) <-2 ) and severe underweight (defined as WAZ <-3 ). To calculate WAZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Mean height-for-age Z-score (HAZ)
Periodo de tiempo: After 24 months of program implementation
|
In 6-59 months old children suffering from SAM or recovering from SAM. Scores will be calculated relative to World Health Organization (WHO) 2006 reference, with a higher score meaning a better outcome |
After 24 months of program implementation
|
|
Mean weight-for-age Z-score (WAZ)
Periodo de tiempo: After 24 months of program implementation
|
In 6-59 months old children suffering from SAM or recovering from SAM. To calculate WAZ scores the 2006 WHO growth reference will be used |
After 24 months of program implementation
|
|
Caregiver's knowledge score
Periodo de tiempo: After 24 months of program implementation
|
The score will be calculated by adding one point for each right answer to a series of questions related to infant and child feeding, child health and hygiene, the condition of severe acute malnutrition, outpatient therapeutic programs, screening of wasting. Questions were specifically developed for the study based on program activities and asked to caregiver of children aged 6-59 months suffering from SAM or recovering from SAM |
After 24 months of program implementation
|
|
Prevalence of appropriate immunization
Periodo de tiempo: After 24 months of program implementation
|
Proportion of children aged 6-18 months with SAM or enrolled in SAM OTP who received all recommended immunizations |
After 24 months of program implementation
|
|
Coverage of the integrated management of acute malnutrition (IMAM) platform
Periodo de tiempo: After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM who attended an IMAM consultation in the previous 15 days (as reported by the caregiver or by an IMAM treatment card) |
After 24 months of program implementation
|
|
Coverage of the community unit platform
Periodo de tiempo: After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM in contact with a CHP in the 2 months preceding the survey for community care-related matter (as reported by the caregiver) |
After 24 months of program implementation
|
|
Coverage of family MUAC
Periodo de tiempo: After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM screened in the month preceding the survey by a family member using a MUAC tape (as reported by the caregiver) |
After 24 months of program implementation
|
|
Coverage of family MUAC training
Periodo de tiempo: After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM for which at least one family member was trained to use MUAC tape (as reported by the caregiver) |
After 24 months of program implementation
|
|
Coverage of MUAC tapes
Periodo de tiempo: After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM for which at least one family member owns a MUAC tape (as reported by the caregiver AND confirmed by observation) |
After 24 months of program implementation
|
|
Coverage of WAZ screening
Periodo de tiempo: After 24 months of program implementation
|
proportion of children aged 6-59 months suffering from SAM or recovering from SAM weighed in the 2 months preceding the survey by a CHP or a health staff using a scale (as reported by the caregiver) |
After 24 months of program implementation
|
|
Period prevalence of wasting treatment coverage in children 6-59 months of age
Periodo de tiempo: After 24 months of program implementation
|
Defined as the proportion of children suffering or recovering from wasting who currently receive treatment. • Wasting defined by weight-for-height Z-score (WHZ) <-2 (relative to World Health Organization (WHO) 2006 reference) or MUAC <125 mm or by the presence of bilateral edema. Children recovering from wasting will be considered to receive treatment if they both attended an IMAM consultation in the previous 15 days (as reported by caregiver OR by a consultation card) AND either: consumed RUTF at least once in the previous 3 days (as reported by the caregiver AND confirmed by observation of >= 1 full or 2 empty RUTF sachets) OR consumed RUSF at least once in the previous 3 days (as reported by the caregiver AND confirmed by observation by the enumerator of >= 1 full or 2 empty RUSF sachets) AND child does not suffer from SAM (as defined above) |
After 24 months of program implementation
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Elodie Becquey, PhD, International Food Policy Research Institute
- Investigador principal: Sophie Ochola, PhD, Kenyatta University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- RSWITCH-Kenya
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
All data will be carefully anonymized and de-identified so that the privacy of participants and research subjects is fully protected. Databases will be anonymized using identification codes. No names, GPS coordinates, dates of birth or other identifying data will be stored in the databases.
At the time of publication of scientific articles presenting primary results, the fully anonymized databases (quantitative data) will become a public good and will be made available to the scientific community, government, and partners.
Marco de tiempo para compartir IPD
At the time of publication of scientific articles presenting primary results.
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .